Dr Petrylak Discusses Psma Directed Therapies In Prostate Cancer

Daniel P. Petrylak, MD, director, Prostate and GU Medical Oncology, Yale Cancer Center, discusses PSMA and its role in prostate cancer treatment.

For more resources and information regarding anticancer targeted therapies: targetedonc.com/

  • Dr. Petrylak Discusses PSMA-Directed Therapies in Prostate Cancer ( Download)
  • Dr. Daniel Petrylak Discusses Novel Bone Targeted Therapies in Prostate Cancer ( Download)
  • Dr. Petrylak on PSMA ADC for Patients with mCRPC ( Download)
  • Dr. Petrylak on a Phase II Trial of PSMA ADC in Taxane-Treated mCRPC ( Download)
  • Dr. Daniel Petrylak Discusses Chemotherapy in Prostate Cancer ( Download)
  • Dr. Petrylak Discusses Custirsen as a Potential Treatment for Prostate Cancer ( Download)
  • Dr. Petrylak on Imaging Approaches in Prostate Cancer ( Download)
  • Dr. Petrylak Explains Prostate Cancer Clinical Trial Difficulties ( Download)
  • Dr. Petrylak on Sequencing Agents in Prostate Cancer ( Download)
  • Dr. Daniel Petrylak Describes the Clinical Investigation of PROSTVAC in Prostate Cancer ( Download)
  • PSMA ADC for prostate cancer ( Download)
  • Dr. Petrylak on Novel Imaging Modalities in Prostate Cancer ( Download)
  • Dr. Daniel Petrylak on Biomarker Discovery in Advanced Prostate Cancer ( Download)
  • Promising Agents for the Treatment of Prostate Cancer ( Download)
  • Dr. Petrylak on Imaging Approaches in Prostate Cancer ( Download)